{"id":1381,"date":"2022-09-21T09:37:03","date_gmt":"2022-09-21T07:37:03","guid":{"rendered":"https:\/\/labolifeint.ditsmarketing.com\/vademecum\/"},"modified":"2025-07-24T08:56:52","modified_gmt":"2025-07-24T06:56:52","slug":"compendium","status":"publish","type":"page","link":"https:\/\/med.labolife.com\/en\/compendium\/","title":{"rendered":"Compendium"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><h1 class=\"w-post-elm post_title entry-title color_link_inherit\">Compendium<\/h1><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_b9d1d30d height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_middle type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"g-cols wpb_row us_custom_ccd693d8 via_flex valign_middle type_default stacking_default\"><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/03\/Compendium.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Compendium<\/h6><div class=\"w-ibanner-desc\"><p>Download<\/p>\n<\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/07\/Compendium-of-micro-immunotherapy-medicines.pdf\" rel=\"noopener\" aria-label=\"Compendium\"><\/a><\/div><\/div><\/div><\/div><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Captura-de-pantalla-2023-02-21-a-las-14.43.28.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Shipping form<\/h6><div class=\"w-ibanner-desc\"><p>Download<\/p>\n<\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Shipping-form.pdf\" rel=\"noopener\" aria-label=\"Shipping form\"><\/a><\/div><\/div><\/div><\/div><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Captura-de-pantalla-2023-02-15-a-las-10.13.04.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Healthcare supporting material<\/h6><div class=\"w-ibanner-desc\"><p>Download<\/p>\n<\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/07\/Micro-immunotherapy-medicines-Healthcare-suporting-material.pdf\" rel=\"noopener\" aria-label=\"Healthcare supporting material\"><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><h4 class=\"w-text\"><span class=\"w-text-h\"><span class=\"w-text-value\">Select a medicine to see its composition and characteristics<\/span><\/span><\/h4><div class=\"w-separator size_small\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>The redesign of our medicine packaging will be gradual and will take place over the next few months, <a href=\"https:\/\/www.labolife.com\/discover-the-new-look-of-our-packaging\/\" target=\"_blank\" rel=\"noopener\">gradually affecting each of the medicines currently on the market<\/a>. It is possible that two different packages temporarily coexist on the market: the old and the new.<\/p>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"w-grid type_grid layout_677 cols_2 popup_page\" id=\"us_grid_1\" data-filterable=\"true\"><style>#us_grid_1 .w-grid-item{padding:0.5rem}#us_grid_1 .w-grid-list{margin:-0.5rem -0.5rem 0.5rem}.w-grid + #us_grid_1 .w-grid-list,.w-grid-none + #us_grid_1 .w-grid-list{margin-top:0.5rem}@media (max-width:956px){#us_grid_1 .w-grid-list{margin:0}#us_grid_1 .w-grid-item{width:100%;padding:0;margin-bottom:0.5rem}}@media (max-width:599px){#us_grid_1 .w-grid-list{margin:0}#us_grid_1 .w-grid-item{width:100%;padding:0;margin-bottom:0.5rem}}.layout_677 .w-grid-item-h{border-radius:2.3rem;box-shadow:0 0rem 0rem rgba(0,0,0,0.1),0 0rem 0rem rgba(0,0,0,0.1);transition-duration:0.3s}.no-touch .layout_677 .w-grid-item-h:hover{box-shadow:0 0.08rem 0.16rem rgba(0,0,0,0.1),0 0.27rem 0.8rem rgba(0,0,0,0.15);z-index:4}.layout_677 .usg_post_title_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_hwrapper_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_hwrapper_1{transform:scale(1) translate(0%,0%);opacity:1;background:var(--color-alt-content-primary)!important;color:var(--color-header-middle-bg)!important}.layout_677 .usg_post_content_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_content_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_2{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_2{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_2{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_2{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_3{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_3{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_3{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_3{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_4{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_4{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_4{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_4{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_5{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_5{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_5{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_5{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_6{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_6{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_6{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_6{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_7{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_7{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_7{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_7{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_1{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_hwrapper_1{color:var(--color-header-middle-bg)!important;border-radius:45px!important;border-right-width:1px!important;border-color:var(--color-header-middle-bg)!important;position:relative!important;animation-name:fade!important;animation-delay:0.2!important;border-right-style:solid!important;background:var(--color-content-secondary)!important}.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important;background:var(--color-header-middle-bg)!important}.layout_677 .usg_post_content_1{font-size:10px!important;line-height:13px!important}.layout_677 .usg_hwrapper_2{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_custom_field_1{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_3{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_2{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_2{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_4{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_3{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_3{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_5{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_4{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_4{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_6{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_5{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_5{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_7{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_6{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_6{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_8{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_7{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_7{font-family:var(--font-h1)!important}@media (min-width:1025px) and (max-width:1280px){.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important}}@media (min-width:601px) and (max-width:1024px){.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important}}@media (max-width:600px){.layout_677 .usg_post_image_1{min-width:140px!important;min-height:200px!important}}<\/style><div class=\"w-grid-list\">\t<article class=\"w-grid-item size_1x1 post-2073 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2073\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lalerg\/\" rel=\"bookmark\" aria-label=\"2LALERG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lalerg\/\" aria-label=\"2LALERG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1715101_LLB_ALERG_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 119 F1- CNK 1715-101<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 17 CH<br \/>\nInterleukin 4 (IL-4): 17, 27 CH<br \/>\nInterleukin 5 (IL-5): 17 CH<br \/>\nInterleukin 6 (IL-6): 17 CH<br \/>\nInterleukin 10 (IL-10): 17 CH<br \/>\nInterleukin 12 (IL-12): 9 CH<br \/>\nInterleukin 13 (IL-13): 17 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 17 CH<br \/>\nTransforming Growth Factor Beta (TGF-\u03b2): 5 CH<br \/>\nPulmo-Histaminum (Pulm. Hist.): 15 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-ALERG ref. 2LALERG<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in allergic disorders.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2077 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2077\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2larth\/\" rel=\"bookmark\" aria-label=\"2LARTH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2larth\/\" aria-label=\"2LARTH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591353_LLB_ARTH_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 36 F1 &#8211; CNK 1591-353<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 10, 17 CH<br \/>\nInterleukin 2 (IL-2): 10, 12 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-ARTH: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-ARTH ref. 2LARTH<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in acute and subacute episodes of inflammation.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2081 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2081\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lc1\/\" rel=\"bookmark\" aria-label=\"2LC1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lc1\/\" aria-label=\"2LC1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591072_LLB_C1_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 2 F1- CNK 1591-072<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 3, 10 CH<br \/>\nInterleukin 4 (IL-4): 6, 10 CH<br \/>\nInterleukin 6 (IL-6): 6, 10 CH<br \/>\nInterleukin 7 (IL-7): 6, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 30 CH<br \/>\nMolgramostim (GMCSF): 5, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 10, 12, 30, 200 K<br \/>\nRibonucleic acid (RNA): 6, 10, 12, 30, 200 K<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C1a: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C1b: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-C1 ref. 2LC1<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in neoplasia of solid tumors as well as in cases of conventional cancer therapies.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2503\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2086 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2086\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lc1-n\/\" rel=\"bookmark\" aria-label=\"2LC1-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lc1-n\/\" aria-label=\"2LC1-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_C1-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 10 F1 &#8211; CNK 2314-813<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nRibonucleic acid (RNA): 6, 12, 30, 200 K<br \/>\nDeoxyribonucleic acid (DNA): 6, 12, 30, 200 K<br \/>\nInterferon Alpha (IFN-a): 3 CH<br \/>\nInterferon Gamma (IFN-g): 6 CH<br \/>\nInterleukin 1 (IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 3 CH<br \/>\nInterleukin 6 (IL-6): 9 CH<br \/>\nInterleukin 7 (IL-7): 4 CH<br \/>\nInterleukin 10 (IL-10): 27 CH<br \/>\nInterleukin 12 (IL-12): 4 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 27 CH<br \/>\nbasic Fibroblast Growth Factor (bFGF): 27 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 27 CH<br \/>\nEpidermal Growth Factor (EGF): 27 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C1a01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C1b01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C1c01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-C1-N Ref. 2LC1-N<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in the areas of oncology related to solid tumors.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2621\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2090 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2090\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lc2\/\" rel=\"bookmark\" aria-label=\"2LC2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lc2\/\" aria-label=\"2LC2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591080_LLB_C2_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 3 F1 &#8211; CNK 1591-080<br \/>\nComposition corresponding to a sequence of 10 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 3, 10 CH<br \/>\nInterleukin 4 (IL-4): 6, 10 CH<br \/>\nInterleukin 6 (IL-6): 6, 10 CH<br \/>\nInterleukin 7 (IL-7): 6, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 30 CH<br \/>\nMolgramostim (GMCSF): 5, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-C2: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-C2 ref. 2LC2<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in neoplasia of solid tumors after a complete remission of more than one year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2507\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2094 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2094\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lchla\/\" rel=\"bookmark\" aria-label=\"2LCHLA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lchla\/\" aria-label=\"2LCHLA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CHLA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 37 F1 &#8211; CNK 1591-098<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 9, 10 CH<br \/>\nInterleukin 2 (IL-2): 9, 10 CH<br \/>\nInterferon Alpha (IFN-a): 9, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CHLA: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-CHLA ref. 2LCHLA<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by Chlamydia trachomatis.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2098 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2098\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lcl1\/\" rel=\"bookmark\" aria-label=\"2LCL1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lcl1\/\" aria-label=\"2LCL1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591106_LLB_CL1_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 4 F1 &#8211; CNK 1591-106<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 9, 10 CH<br \/>\nInterleukin 4 (IL-4): 9, 10 CH<br \/>\nInterleukin 6 (IL-6): 9, 10 CH<br \/>\nInterleukin 7 (IL-7): 6, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 30 CH<br \/>\nMolgramostim. (GMCSF): 5, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 10, 12, 30, 200 K<br \/>\nRibonucleic acid (RNA): 6, 10, 12, 30, 200 K<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CL1a: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CL1b: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CL1 ref. 2LCL1<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in haematological malignancies such as chronic lymphocytic leukemia, acute lymphoblastic leukemia, Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma, as well as in cases of conventional cancer therapies.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2515\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2102 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2102\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lcl2\/\" rel=\"bookmark\" aria-label=\"2LCL2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lcl2\/\" aria-label=\"2LCL2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CL2_2023_gen1-245x160.png\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 5 F1 &#8211; CNK 1591-114<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 9, 10 CH<br \/>\nInterleukin 4 (IL-4): 9, 10 CH<br \/>\nInterleukin 6 (IL-6): 9, 10 CH<br \/>\nInterleukin 7 (IL-7): 6, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nTransforming Growth Factor Beta (TGF-b) 10, 30 CH<br \/>\nMolgramostim. (GMCSF) 5, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CL2: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-CL2 ref. 2LCL2<\/p>\n<p>The areas of use derive from the properties and dilutions of the components. They include immune support in haematological malignancies such as chronic lymphocytic leukemia, acute lymphoblastic leukemia, Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma after a complete remission of more than one year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2521\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2106 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2106\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lclm\/\" rel=\"bookmark\" aria-label=\"2LCLM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lclm\/\" aria-label=\"2LCLM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/11\/1591122_LLB_CLM_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 6 F1 &#8211; CNK 1591-122<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 9, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 30 CH<br \/>\nMolgramostim. (GMCSF): 10, 17 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 10, 12, 30, 200 K<br \/>\nRibonucleic acid (RNA): 6, 10, 12, 30, 200 K<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CLMa: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CLMb: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-CLM ref. 2LCLM<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in haematological malignancies such as acute<br \/>\nmyeloid leukemia or chronic myeloid leukemia, during the attack and\/or the<br \/>\nmaintenance phase, as well as in support of conventional cancer therapies.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2110 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2110\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lcmv\/\" rel=\"bookmark\" aria-label=\"2LCMV\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lcmv\/\" aria-label=\"2LCMV\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CMV_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 38 F1 &#8211; CNK 1591-130<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 7, 10 CH<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nInterferon Alpha (IFN-a): 7, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-CMV: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-CMV ref. 2LCMV<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by cytomegalovirus as well\u00a0as in cases of chronic fatigue syndrome, which might be caused by CMV, in the\u00a0context of a \u00abnormal\u00bb or deficient immune status.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<br \/>\n<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2529\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2114 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2114\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ldep\/\" rel=\"bookmark\" aria-label=\"2LDEP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ldep\/\" aria-label=\"2LDEP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_DEP_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 310 F1 &#8211; CNK 2601-227<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 27 CH<br \/>\nInterleukin 2 (IL-2): 9 CH<br \/>\nInterleukin 4 (IL-4): 5 CH<br \/>\nInterleukin 6 (IL-6): 17 CH<br \/>\nInterleukin 10 (IL-10): 9 CH<br \/>\nInterleukin 12 (IL-12): 17 CH<br \/>\nNeurotrophin 3 (NT3 ): 4 CH<br \/>\nErythropo\u00efetin (EPO): 4 CH<br \/>\nInterferon gamma (IFN-\u03b3): 27 CH<br \/>\nCorticotropin Releasing Factor (CRF): 27 CH<br \/>\nTumor Necrosis Factor alpha (TNF-\u03b1): 27 CH<br \/>\nNeurotrophin 4 (NT4): 4 CH<br \/>\nTransforming Growth Factor alpha (TGF-\u03b1): 4 CH<br \/>\nTransforming Growth Factor beta (TGF-\u03b2): 4 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-DEPa-02: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-DEPb-02: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-DEPc-02: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-DEP ref. 2LDEP<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in pathologies associated with depression symptoms.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2653\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2118 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2118\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ldmla\/\" rel=\"bookmark\" aria-label=\"2LDMLA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ldmla\/\" aria-label=\"2LDMLA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_DMLA_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 129 F1 &#8211; CNK 2230-837<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nAngiogenin: 27 CH<br \/>\nBrain Derived Neurotrophic Factor (BDNF): 5 CH<br \/>\nCiliary Neuro Trophic Factor (CNTF): 4 CH<br \/>\nFibroblast Growth Factor Basic (bFGF): 9 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 17 CH<br \/>\nInterleukin 1 (IL-1): 17 CH<br \/>\nMacrophage Inflammatory Protein 1 Alpha (MIP-1a): 27 CH<br \/>\nMacrophage Inflammatory Protein 1 Beta (MIP-1b): 27 CH<br \/>\nNerve Growth Factor (NGF): 4 CH<br \/>\nPigment Derived Epithelial Factor (PDEF): 3 CH<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): 9 CH<br \/>\nRantes: 27 CH<br \/>\nSubstance P: 27 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 9 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-DMLAa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-DMLAb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-DMLA ref. 2LDMLA<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support linked to age-related macular degeneration.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2617\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2122 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2122\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2leai\/\" rel=\"bookmark\" aria-label=\"2LEAI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2leai\/\" aria-label=\"2LEAI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591155_LLB_EAI_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 35 F1 &#8211; CNK 1591-155<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 10, 27 CH<br \/>\nInterleukin 2 (IL-2): 9, 10 CH<br \/>\nInterleukin 5 (IL-5): 9, 10 CH<br \/>\nInterleukin 6 (IL-6): 7, 10 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 9, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 27 CH<br \/>\nProstaglandin E2 (PGE2): 3, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-EAI: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-EAI ref. 2LEAI<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in all cases of immune hyperreactivity.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2531\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2126 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2126\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lebv\/\" rel=\"bookmark\" aria-label=\"2LEBV\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lebv\/\" aria-label=\"2LEBV\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB-AMM_EBV_v1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 39 F1 &#8211; CNK 1591-163<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 7, 10 CH<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-EBV: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-EBV ref. 2LEBV.<\/p>\n<p>Prescription medicine in Belgium.<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by the Epstein-Barr virus as\u00a0well as in cases of chronic fatigue syndrome, which is often caused by the EBV,\u00a0in the context of a \u201cnormal\u201d or deficient immune status.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2694\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2130 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2130\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2leid\/\" rel=\"bookmark\" aria-label=\"2LEID\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2leid\/\" aria-label=\"2LEID\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_EID_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 34 F1 &#8211; CNK 1591-171<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 5, 10 CH<br \/>\nInterleukin 2 (IL-2): 5, 10 CH<br \/>\nInterleukin 5 (IL-5): 6, 10 CH<br \/>\nInterleukin 6 (IL-6): 6, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 30 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-EID: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-EID ref. 2LEID<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in acute, chronic and recurrent infections, in the\u00a0context of \u201cnormal\u201d or deficient immune status.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2541\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2134 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2134\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2leid-n\/\" rel=\"bookmark\" aria-label=\"2LEID-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2leid-n\/\" aria-label=\"2LEID-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_EID-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 198 F1 &#8211; CNK 2362-119<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 7 CH<br \/>\nInterleukin 2 (IL-2): 5 CH<br \/>\nInterleukin 3 (IL-3): 3 CH<br \/>\nInterleukin 4 (IL-4): 27 CH<br \/>\nInterleukin 6 (IL-6): 6 CH<br \/>\nInterleukin 10 (IL-10): 17 CH<br \/>\nInterleukin 12 (IL-12): 5 CH<br \/>\nRibonucleic acid (RNA): 8 CH<br \/>\nDeoxyribonucleic acid (DNA): 8 CH<br \/>\nGranulocyte Colony Stimulating Factor (GCSF): 5 CH<br \/>\nInterferon Gamma (IFN-g): 6 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5 CH<br \/>\nMolgramostim (GMCSF): 5 CH<br \/>\nTransforming Growth Factor Beta (TGF-b) 27, 30 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-EIDa-02: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-EIDb-02: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<\/p>\n<p>Excip. Saccharos. pro cap. gel. una<br \/>\nCompositio cytokinae et SNA\u00ae-EID-N Ref. 2LEID-N<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in acute, chronic and recurrent infections in\u00a0cases of immunodeficiency, particularly in the field of ENT infections.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2138 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2138\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lha\/\" rel=\"bookmark\" aria-label=\"2LHA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lha\/\" aria-label=\"2LHA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591197_LLB_HA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 27 F1 &#8211; CNK 1591-197<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nInterleukin 6 (IL-6): 9, 10 CH<br \/>\nPhosphorus (PHOS): 9, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HA: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-HA ref. 2LHA<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in viral hepatitis A.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2142 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2142\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lhc\/\" rel=\"bookmark\" aria-label=\"2LHC\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lhc\/\" aria-label=\"2LHC\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591213_LLB_HC_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 29 F1 &#8211; CNK 1591-213<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nInterleukin 6 (IL-6): 9, 10 CH<br \/>\nInterferon Alpha (IFN-a): 4, 10 CH<br \/>\nPhosphorus (PHOS): 9, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HC: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-HC ref. 2LHC<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in viral hepatitis B, C or D, in the context of a\u00a0\u201cnormal\u201d or deficient immune status.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2146 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2146\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lhcx\/\" rel=\"bookmark\" aria-label=\"2LHCX\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lhcx\/\" aria-label=\"2LHCX\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/11\/1591221_LLB_HCX_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 32 F1 &#8211; CNK 1591-221<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 10, 30 CH<br \/>\nInterleukin 2 (IL-2): 10, 27 CH<br \/>\nInterleukin 5 (IL-5): 10, 30 CH<br \/>\nInterleukin 6 (IL-6): 10, 30 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 30 CH<br \/>\nPhosphorus (PHOS): 10, 16 CH<br \/>\nRibonucleic acid (RNA): 8, 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HCX: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<\/p>\n<p>Excip. Saccharos. pro caps. gel. Una<br \/>\nCompositio cytokinae et SNA\u00ae-HCX ref. 2LHCX<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in viral hepatitis B, C or D, in the context of\u00a0immune hyperreactivity.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2553\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2150 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2150\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lherp\/\" rel=\"bookmark\" aria-label=\"2LHERP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lherp\/\" aria-label=\"2LHERP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/11\/1591254_LLB_HERP_2023_gen4-5-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 40 F1 &#8211; CNK 1591-254<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HER 1: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HER 2: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-HERP ref. 2LHERP.<\/p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Prescription medicine in Belgium.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in viral infections caused by herpes simplex type\u00a01 and 2.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2154 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2154\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2linflam\/\" rel=\"bookmark\" aria-label=\"2LINFLAM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2linflam\/\" aria-label=\"2LINFLAM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_INFLAM_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 127 F1 &#8211; CNK 2330-579<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 17 CH<br \/>\nInterleukin 1 Receptor Antagonist (IL-1 Ra): 3 CH<br \/>\nInterleukin 2 (IL-2): 9 CH<br \/>\nInterleukin 4 (IL-4): 7 CH<br \/>\nInterleukin 6 (IL-6): 9 CH<br \/>\nInterleukin 8 (IL-8): 9 CH<br \/>\nInterleukin 10 (IL-10): 4 CH<br \/>\nInterleukin 13 (IL-13): 9 CH<br \/>\nCiliary Neuro Trophic Factor (CNTF): 17 CH<br \/>\nLeukemia Inhibitory Factor (LIF): 17 CH<br \/>\nOncostatin M (OSM): 9 CH<br \/>\nPlateled Derived Growth Factor (PDGF): 5 CH<br \/>\nProstaglandine E2 (PGE2): 200 K<br \/>\nRantes: 17 CH<br \/>\nTransforming Growth Factor beta (TGF-b): 5 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-INFLAMa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-INFLAMb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-INFLAM ref. 2LINFLAM<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in inflammatory processes.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2702\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2158 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2158\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lkah\/\" rel=\"bookmark\" aria-label=\"2LKAH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lkah\/\" aria-label=\"2LKAH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1591262_LLB_KAH_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 24 F1 &#8211; CNK 1591-262<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 6, 10 CH<br \/>\nInterleukin 2 (IL-2): 10, 27 CH<br \/>\nInterleukin 3 (IL-3): 10, 27 CH<br \/>\nInterleukin 5 (IL-5): 10, 27 CH<br \/>\nInterleukin 6 (IL-6): 10, 30 CH<br \/>\nInterferon Alpha (IFN-a): 5, 10 CH<br \/>\nInterferon Gamma (IFN-g): 6, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 10, 15 CH<br \/>\nMolgramostim (GMCSF): 10, 17 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 5, 10 CH<br \/>\nErythropoietin (EPO): 3, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 10, 12, 30, 200 K<br \/>\nRibonucleic acid (RNA): 6, 10, 12, 30, 200 K<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-KAHa: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-KAHb: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-KAH ref. 2LKAH<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in multiple myeloma (Kahler\u2019s disease) during\u00a0the attack and\/or maintenance phase as a supplement to conventional cancer\u00a0therapies.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2162 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2162\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2llnh1\/\" rel=\"bookmark\" aria-label=\"2LLNH1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2llnh1\/\" aria-label=\"2LLNH1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/3119559_LLB_LNH1_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 151 F1 \u2013 CNK 3119-559<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 17 CH<br \/>\nInterleukin 6 (IL-6): 27 CH<br \/>\nInterleukin 7 (IL-7): 27 CH<br \/>\nInterleukin 9 (IL-9): 27 CH<br \/>\nInterleukin 10 (IL- 10): 27 CH<br \/>\nInterleukin 12 (IL-12): 9 CH<br \/>\nFibroblast Growth Factor basic (bFGF): 27 CH<br \/>\nInsulin Growth Factor 1 (IGF1): 27 CH<br \/>\nInterferon alpha (IFN-a): 7 CH<br \/>\nInterferon Beta (IFN-\u03b2): 6 CH<br \/>\nInterferon gamma (IFN-\u03b3): 6 CH<br \/>\nDeoxyribonucleic acid (DNA): 6, 12, 30, 200 K<br \/>\nRibonucleic acid (RNA): 6, 12, 30, 200 K<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): 17, 27 CH<br \/>\nStem Cell Factor (SCF): 27 CH<br \/>\nTransforming Growth Factor beta (TGF-\u03b2): 17 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 5 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-LNH1a-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-LNH1b-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-LNH1c-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-LNH1d-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-LNH1 ref. 2LLNH1<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in hematological malignancies like non-Hodgkin\u2019s\u00a0lymphoma in the case of conventional cancer therapies.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2166 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2166\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lmda\/\" rel=\"bookmark\" aria-label=\"2LMDA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lmda\/\" aria-label=\"2LMDA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2500981_LLB_MdA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>Composition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 9 CH<br \/>\nInterleukin 6 (IL-6): 7 CH<br \/>\nInterleukin 13 (IL-13): 5 CH<br \/>\nGlial Derived Neurotrophic Factor (GDNF): 5 CH<br \/>\nBrain Derived Neurotrophic Factor (BDNF): 5 CH<br \/>\nCiliary Neuro Trophic Factor (CNTF): 4 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 9 CH<br \/>\nErythropoietin (EPO): 3 CH<br \/>\nFibroblast Growth Factor basic (bFGF): 5 CH<br \/>\nNerve Growth Factor (NGF): 7 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 4 CH<br \/>\nNeurotrophin 3 (NT3): 5 CH<br \/>\nNeurotrophin 4 (NT4): 5 CH<br \/>\nBeta-N-Methylamino-L-Alanine (bMAA): 27 CH<br \/>\nSubstance P: 4 CH<br \/>\nNeuropeptide Y (NPY): 7 CH<br \/>\nBeta-Amyloid-Protein (b amyl. protein): 9 CH<br \/>\nSomatostatin (S.S): 4 CH<br \/>\nDeoxyribonucleic acid (DNA): 8 CH<br \/>\nRibonucleic acid (RNA): 8 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MdAa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MdAb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-MdA ref. 2LMdA<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in pathologies associated with Alzheimer\u2019s\u00a0disease symptoms.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2170 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2170\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lmem-senior\/\" rel=\"bookmark\" aria-label=\"2LMEM-SENIOR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lmem-senior\/\" aria-label=\"2LMEM-SENIOR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MEM-SENIOR_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 225 F1 &#8211; CNK 2230-829<br \/>\nComposition corresponding to a sequence of 10 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 17 CH<br \/>\nInterleukin 6 (IL-6): 5 CH<br \/>\nInterleukin 12 (IL-12): 9 CH<br \/>\nInterleukin 13 (IL-13): 4 CH<br \/>\nBrain Derived Neurotrophic Factor (BDNF): 5 CH<br \/>\nCiliary Neuro Trophic Factor (CNTF): 4 CH<br \/>\nEpidermal Growth Factor (EGF): 7 CH<br \/>\nErythropo\u00efetin (EPO) 4 CH<br \/>\nFibroblast Growth Factor Basic (bFGF): 5 CH<br \/>\nGlial Derived Neurotrophic Factor (GDNF): 5 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 7 CH<br \/>\nInterferon Beta (IFN-b): 3 CH<br \/>\nLeukemia Inhibitory Factor (LIF): 5 CH<br \/>\nNerve Growth Factor (NGF): 4 CH<br \/>\nNeurotrophin 3 (NT3): 5 CH<br \/>\nNeurotrophin 4 (NT4): 5 CH<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): 5 CH<br \/>\nPregnenolon. Sulf. (PREG\u2019S): 3 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 5 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 9 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MEM-SENIORa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MEM-SENIORb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MEM-SENIOR ref. 2LMEM-SENIOR<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in case of pathologies associated with age-related memory loss.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2613\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2174 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2174\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lmici\/\" rel=\"bookmark\" aria-label=\"2LMICI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lmici\/\" aria-label=\"2LMICI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MICI_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>Composition corresponding to a sequence of 10 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 27 CH<br \/>\nInterleukin 2 (IL-2): 9 CH<br \/>\nInterleukin 4 (IL-4): 9 CH<br \/>\nInterleukin 6 (IL-6): 9 CH<br \/>\nInterleukin 8 (IL-8): 17 CH<br \/>\nInterleukin 10 (IL-10): 5 CH<br \/>\nIL1 Receptor antagonist (IL-1 Ra): 3 CH<br \/>\nInterCellular Adhesion Molecule (ICAM): 27 CH<br \/>\nInterferon Gamma (IFN-g): 17 CH<br \/>\nTransforming Growth Factor beta (TGF-b): 9 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 27 CH<br \/>\nProstaglandinum E2 (PGE2): 200 K<br \/>\nAcid. Nucleic. Specif SNA\u00ae-HLA II-01: 18 CH<br \/>\nAcid. Nucleic. Specif SNA\u00ae-MICIb-01: 18 CH<br \/>\nAcid. Nucleic. Specif SNA\u00ae-MICIa-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MICI ref. 2LMICI<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in cases associated with chronic inflammatory bowel diseases.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2637\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2178 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2178\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lmireg\/\" rel=\"bookmark\" aria-label=\"2LMIREG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lmireg\/\" aria-label=\"2LMIREG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MIREG_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 46 F1 &#8211; CNK 1591-270<br \/>\nComposition corresponding to a sequence of 10 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 10, 27 CH<br \/>\nInterleukin 2 (IL-2): 10, 27 CH<br \/>\nInterleukin 5 (IL-5): 10, 27 CH<br \/>\nInterleukin 6 (IL-6): 10, 27 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 27 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 10, 15 CH<br \/>\nProstaglandin E2 (PGE2): 3, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 10, 18 CH<br \/>\nRibonucleic acid (RNA): 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MIREG: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-MIREG ref. 2LMIREG<br \/>\nThe areas of use derive from the properties and dilutions of the components. They include immune support in various genetic diseases.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2561\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2182 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2182\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lmisen\/\" rel=\"bookmark\" aria-label=\"2LMISEN\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lmisen\/\" aria-label=\"2LMISEN\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591288_LLB_MISEN_2023_gen2-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>Composition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nEpidermal Growth Factor (EGF): 7, 10 CH<br \/>\nDehydroepiandrosterone (DHEA): 3, 10 CH<br \/>\nDimethyl Sulfoxide (DMSO): 3, 10 CH<br \/>\nRibonucleic acid (RNA): 9, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MISEN: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-MISEN ref. 2LMISEN<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in stress and aging conditions as well as in the\u00a0associated diseases.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2565\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2186 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2186\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2losteo-n\/\" rel=\"bookmark\" aria-label=\"2LOSTEO-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2losteo-n\/\" aria-label=\"2LOSTEO-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_OSTEO-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 207 F1 &#8211; CNK 2209-377<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 17 CH<br \/>\nInterleukin 6 (IL-6): 17 CH<br \/>\nInterleukin 11 (IL-11): 15 CH<br \/>\nBone Morphogenetic Protein-2 (BMP-2): 5 CH<br \/>\nBone Morphogenetic Protein-4 (BMP-4): 5 CH<br \/>\nDeoxyribonucleic acid (DNA): 5 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 9 CH<br \/>\nMolgramostim (GMCSF): 15 CH<br \/>\nNatrum Silico Fluoricum (Nat.Sil.Fl.): 3 CH<br \/>\nRibonucleic acid (RNA): 5 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 5 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-OSTEOa-02: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-OSTEOb-02: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-OSTEO-N ref. 2LOSTEO-N<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in cases of fractures and bone deficiencies, such\u00a0as age-related or postmenopausal osteoporosis.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2605\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2190 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2190\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lpapi\/\" rel=\"bookmark\" aria-label=\"2LPAPI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lpapi\/\" aria-label=\"2LPAPI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1591296_LLB_PAPI_2023_gen4-5-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 41 F1 &#8211; CNK 1591-296<br \/>\nComposition corresponding to a sequence of 5 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 10, 17 CH<br \/>\nInterleukin 2 (IL-2): 10, 17 CH<br \/>\nInterferon Alpha (IFN-a): 10, 17 CH<br \/>\nCyclosporin A (CsA): 7, 10, 17 CH<br \/>\nRibonucleic acid (RNA): 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-PAPI: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule.<br \/>\nCompositio cytokinae et SNA\u00ae-PAPI ref. 2LPAPI.<\/p>\n<p>Prescription medicine in Belgium.<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by papillomavirus (HPV) and\u00a0their consequences: anogenital condyloma and cervical dysplasia.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2194 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2194\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lpark\/\" rel=\"bookmark\" aria-label=\"2LPARK\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lpark\/\" aria-label=\"2LPARK\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153_LLB_PARK_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 173 F1- CNK 1785-153<br \/>\nComposition corresponding to a sequence of 10 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 17 CH<br \/>\nInterleukin 2 (IL-2): 17 CH<br \/>\nInterleukin 6 (IL-6): 17 CH<br \/>\nInterleukin 12 (IL-12): 17 CH<br \/>\nBrain Derived Neurotrophic Factor (BDNF): 4 CH<br \/>\nBeta N Methyl Amino Alanin. (bMAA): 27 CH<br \/>\nCiliar Neurotrophic Factor (CNTF): 4 CH<br \/>\nErythropoietin (EPO): 3 CH<br \/>\nGlial cell-line Derived Neurotrophic Factor (GDNF): 4 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 4 CH<br \/>\nNeurotensin (NT): 4 CH<br \/>\nNeurotrophin 3 (NT3): 4 CH<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): 4 CH<br \/>\nSomatostatin (SS): 4 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 4 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 17 CH<br \/>\nRibonucleic acid (RNA): 8 CH<br \/>\nDeoxyribonucleic acid (DNA): 8 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-PARK ref. 2LPARK<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include a trophic contribution and immune support in different disorders of the central nervous system, which lead to the degeneration of dopaminergic neurons within the brainstem, which is the basis of Parkinson\u2019s disease.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2669\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2198 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2198\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lpr\/\" rel=\"bookmark\" aria-label=\"2LPR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lpr\/\" aria-label=\"2LPR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_PR_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 141 F1 \u2013 CNK 2500-999<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 27 CH<br \/>\nInterleukin 2 (IL-2): 17 CH<br \/>\nInterleukin 4 (IL-4): 5 CH<br \/>\nInterleukin 6 (IL-6): 27 CH<br \/>\nInterleukin 8 (IL-8): 27 CH<br \/>\nInterleukin 10 (IL-10): 5 CH<br \/>\nInterleukin 12 (IL-12): 17 CH<br \/>\nInterleukin 13 (IL-13): 4 CH<br \/>\nInterleukin 15 (IL-15): 17 CH<br \/>\nInterferon gamma (IFN-g): 17 CH<br \/>\nIL1 Receptor antagonist (IL-1 Ra): 3 CH<br \/>\nAngiogenin: 30 CH<br \/>\nFibroblast Growth Factor basic (bFGF): 27 CH<br \/>\nMolgramostim (GMCSF): 27 CH<br \/>\nMonocyte Colony Stimulating (MCSF): 27 CH<br \/>\nPlateled Derived Growth Factor (PDGF): 27 CH<br \/>\nTransforming Growth Factor beta (TGF-\u03b2): 7 CH<br \/>\nTumor Necrosis Factor alpha (TNF-\u03b1): 27 CH<br \/>\nVascular Endothelial Growth Factor (VEGF): 30 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-PRa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-PRb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-PR ref. 2LPR<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in pathologies associated with the symptoms of\u00a0rheumatoid arthritis.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2645\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2202 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2202\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lpso\/\" rel=\"bookmark\" aria-label=\"2LPSO\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lpso\/\" aria-label=\"2LPSO\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/01\/LLB_PSO_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 133 F1 &#8211; CNK 2362-127<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 6 (IL-6): 27 CH<br \/>\nInterleukin 8 (IL-8): 27 CH<br \/>\nInterleukin 10 (IL-10): 5 CH<br \/>\nInterleukin 13 (IL-13): 4 CH<br \/>\nInterleukin 20 (IL-20): 27 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-\u03b1): 27 CH<br \/>\nInterferon Gamma (IFN-\u03b3): 27 CH<br \/>\nFibroblast Growth Factor basique (bFGF): 27 CH<br \/>\nEpidermal Growth Factor (EGF): 27 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 27 CH<br \/>\nKeratinocyt Growth Factor (KGF): 27 CH<br \/>\nTransforming Growth Factor Alpha (TGF-\u03b1): 4 CH<br \/>\nVascular Endothelial Growth Factor (VEGF): 27 CH<br \/>\nCyclosporin A (CsA): 4 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-PSOa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-PSOb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule.<br \/>\nCompositio cytokinae et SNA\u00ae-PSO ref. 2LPSO<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in pathologies associated with psoriasis.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2633\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2206 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2206\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ls1\/\" rel=\"bookmark\" aria-label=\"2LS1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ls1\/\" aria-label=\"2LS1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591304_LLB_S1_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 25 F1 &#8211; CNK 1591-304<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 5, 10 CH<br \/>\nInterleukin 3 (IL-3): 3, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 9, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 17 CH<br \/>\nCyclosporin A (CsA): 5, 10, 17 CH<br \/>\nErythropoietin (EPO): 3, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-S1: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-S1 ref. 2LS1<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in HIV infections, at all stages of the disease, as\u00a0a supplement to conventional therapies.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2573\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2248 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2248\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ls2\/\" rel=\"bookmark\" aria-label=\"2LS2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ls2\/\" aria-label=\"2LS2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_S2_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 26 F1 &#8211; CNK 1591-312<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 5, 10 CH<br \/>\nInterleukin 3 (IL-3): 3, 10 CH<br \/>\nInterferon Alpha (IFN-a): 3, 10 CH<br \/>\nInterferon Gamma (IFN-g): 9, 10 CH<br \/>\nCyclosporin A (CsA): 5, 10, 17 CH<br \/>\nErythropoietin (EPO): 3, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 17 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-S2: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-S2 ref. 2LS2<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support, in addition to 2LS1, in case of opportunistic\u00a0infections as a complement to conventional therapies targeting infection\u00a0control.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2577\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2211 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2211\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lsen\/\" rel=\"bookmark\" aria-label=\"2LSEN\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lsen\/\" aria-label=\"2LSEN\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_SEN_2023_gen3_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 113 F1 &#8211; CNK 2960-433<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nCiliary Neuro Trophic Factor (CNTF): 4 CH<br \/>\nDehydroepiandrosterone (DHEA): 3 CH<br \/>\nDeoxyribonucleic acid (DNA): 8 CH<br \/>\nEpidermal Growth Factor (EGF): 7 CH<br \/>\nFibroblast Growth Factor basic (FGFb): 5 CH<br \/>\nGlial Derived Neurotrophic Factor (GDNF): 5 CH<br \/>\nInsulin Growth Factor 1 (IGF1): 4 CH<br \/>\nInterferon Beta (IFN-b): 7 CH<br \/>\nInterleukin 1(IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 9 CH<br \/>\nInterleukin 6 (IL-6): 5 CH<br \/>\nInterleukin 12 (IL-12): 9 CH<br \/>\nInterleukin 13 (IL-13): 7 CH<br \/>\nLeukemia Inhibitory Factor (LIF): 5 CH<br \/>\nNerve Growth Factor (NGF): 4 CH<br \/>\nNeurotrophin 3 (NT3): 5 CH<br \/>\nNeurotrophin 4 (NT4): 5 CH<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): 5 CH<br \/>\nRibonucleic acid (RNA): 8 CH<br \/>\nTransforming Growth Factor beta (TGF-b): 5 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 9 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MISENa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MISENb-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MISENc-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-MISENd-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-SEN ref. 2LSEN<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in cell and tissue aging and their related disorders.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2657\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2215 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2215\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lsep\/\" rel=\"bookmark\" aria-label=\"2LSEP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lsep\/\" aria-label=\"2LSEP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785146_LLB_SEP_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 167 F 1 &#8211; CNK 1785-146<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 9 CH<br \/>\nInterleukin 2 (IL-2): 27 CH<br \/>\nInterleukin 4 (IL-4): 4 CH<br \/>\nInterleukin 6 (IL-6): 17 CH<br \/>\nInterleukin 10 (IL-10): 4 CH<br \/>\nInterleukin 12 (IL-12): 27 CH<br \/>\nInterleukin 13 (IL-13): 17 CH<br \/>\nBasic Fibroblast Growth Factor (bFGF): 4 CH<br \/>\nCiliary Neurotrophic Factor (CNTF): 4 CH<br \/>\nEpidermal Growth Factor (EGF): 4 CH<br \/>\nErythropoietin (EPO): 3 CH<br \/>\nGlial. Deriv. Neurotroph. Fact. (GDNF): 4 CH<br \/>\nInterferon Beta 1-a (IFN b-1a): 3 CH<br \/>\nInterferon Gamma (IFN-g): 27 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 4 CH<br \/>\nMacrophage inflammatory protein 1 Alpha (MIP-1a): 27 CH<br \/>\nNerve Growth Factor (NGF): 4 CH<br \/>\nNeutrophin 3 (NT3): 4 CH<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): 4 CH<br \/>\nRantes: 27 CH<br \/>\nTransforming Growth Factor Beta (TGF-b): 4 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-SEPa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-SEPb-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-SEPc-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et\u00a0SNA\u00ae-SEP ref. 2LSEP<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include a trophic contribution and immune support in case of demyelinating\u00a0diseases of the central nervous system, such as multiple sclerosis.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2597\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2219 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2219\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lsleepreg\/\" rel=\"bookmark\" aria-label=\"2LSLEEPREG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lsleepreg\/\" aria-label=\"2LSLEEPREG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/2230811_LLB_SLEEPREG_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 318 F1 &#8211; CNK 2230-811<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 4 (IL-4): 27 CH<br \/>\nInterleukin 6 (IL-6): 4 CH<br \/>\nInterleukin 10 (IL-10): 27 CH<br \/>\nInterleukin 13 (IL-13): 27 CH<br \/>\nInterleukin 1 Beta (IL-1b): 4 CH<br \/>\nBrain Derived Neurotrophic Factor (BDNF): 12, 30 K<br \/>\nBeta Endorphin (b-Endorphin): 9 CH<br \/>\nIL1 Receptor antagonist (IL-1Ra): 27 CH<br \/>\nInterferon Beta (IFN-b): 4 CH<br \/>\nNerve Growth Factor (NGF): 12, 30 K<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 4 CH<br \/>\nVasoactive Intestinal Peptide (VIP): 4 CH<br \/>\nAcid. Nucleic Specif. SNA\u00ae-HLA I-01: 18 CH<br \/>\nAcid. Nucleic Specif. SNA\u00ae-SLEEPREGa-01: 18 CH<br \/>\nAcid. Nucleic Specif. SNA\u00ae-SLEEPREGb-01: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-SLEEPREG ref. 2LSLEEPREG<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in sleepdisorder, its regulation and the falling\u00a0asleep process.<br \/>\nThe granules should be taken before retiring to bed, at least one hour\u00a0after the last meal of the day.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2608\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2223 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2223\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ltnm\/\" rel=\"bookmark\" aria-label=\"2LTNM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ltnm\/\" aria-label=\"2LTNM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/2601193_LLB_TNM_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 192 F1 \u2013 CNK 2601-193<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 6 (IL-6): 27 CH<br \/>\nInterleukin 12 (IL-12): 4 CH<br \/>\nInterferon alpha (IFN-a): 3 CH<br \/>\nRibonucleic acid (RNA): 6, 12, 30, 200 K<br \/>\nCiliary Neuro Trophic Factor (CNTF): 27 CH<br \/>\nDeoxyribonucleic acid (DNA): 6, 12, 30, 200 K<br \/>\nEpidermal Growth Factor (EGF): 27 CH<br \/>\nInsulin Growth Factor 1 (IGF-1): 27 CH<br \/>\nAngiogenin: 27 CH<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): 7 CH<br \/>\nSomatostatin (S.S): 27 CH<br \/>\nTransforming Growth Factor beta (TGF-b): 27 CH<br \/>\nTumor Necrosis Factor alpha (TNF-a): 7 CH<br \/>\nVascular Endothelial Growth Factor (VEGF): 27 CH<br \/>\nLeukemia Inhibitory Factor (LIF): 9 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-TNMa-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-TNMb-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-TNMc-01: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-TNM ref. 2LTNM<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in pathologies associated to symptoms of malignant\u00a0neurological tumors.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2647\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2227 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2227\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2ltoxo\/\" rel=\"bookmark\" aria-label=\"2LTOXO\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2ltoxo\/\" aria-label=\"2LTOXO\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591320_LLB_TOXO_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 42 F1- CNK 1591-320<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 7, 10 CH<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nInterferon Gamma (IFN-g): 7, 10 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 7, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-TOXO: 10, 16 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-TOXO ref. 2LTOXO<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by Toxoplasma gondii as\u00a0well as in cases of chronic fatigue syndrome, which may also be caused by a\u00a0parasite.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2233 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2233\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lveru\/\" rel=\"bookmark\" aria-label=\"2LVERU\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lveru\/\" aria-label=\"2LVERU\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591338_LLB_VERU_2023_gen4-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 43 F1- CNK 1591-338<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 10, 17 CH<br \/>\nInterleukin 2 (IL-2): 10, 17 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nInterferon Alpha (IFN-a): 10, 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-VERU: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-VERU ref. 2LVERU<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by papillomavirus like banal\u00a0warts (verruca vulgaris, plana plantaris), as well as in cases of multiple, recurrent\u00a0or treatment resistant warts.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1831\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2237 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2237\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lveru-junior\/\" rel=\"bookmark\" aria-label=\"2LVERU-JUNIOR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lveru-junior\/\" aria-label=\"2LVERU-JUNIOR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/3595600_LLB_VERUJUNIOR_2023_gen4-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 43 F1- CNK 1591-338<br \/>\nComposition corresponding to a sequence of 5 capsules:<br \/>\nFormula:<br \/>\nInterleukin 1 (IL-1): 10, 17 CH<br \/>\nInterleukin 2 (IL-2): 10, 17 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nInterferon Alpha (IFN-a): 10, 17 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-VERU: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule.<br \/>\nCompositio cytokinae et SNA\u00ae-VERU ref. 2LVERU.<\/p>\n<p>Prescription medicine in Belgium.<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in infections caused by papillomavirus like banal warts (verruca vulgaris, plana plantaris), as well as in cases of multiple, recurrent or treatment resistant warts.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2689\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2241 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2241\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lxfs\/\" rel=\"bookmark\" aria-label=\"2LXFS\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lxfs\/\" aria-label=\"2LXFS\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_XFS_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 44 F1 &#8211; CNK 1591-346<br \/>\nComposition corresponding to a sequence of 10 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 1 (IL-1): 10, 12 CH<br \/>\nInterleukin 2 (IL-2): 10, 12 CH<br \/>\nInterferon Alpha (IFN-a): 6, 10 DH<br \/>\nInterferon Gamma (IFN-g): 10, 17 CH<br \/>\nTumor Necrosis Factor Alpha (TNF-a): 10, 17 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH et 10, 30 K<br \/>\nSpecific Nucleic Acid SNA\u00ae-XFSa: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-XFSb: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-XFSc: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-XFS ref. 2LXFS<\/p>\n<p>The areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in chronic infections, generally caused by the\u00a0Epstein-Barr virus, the cytomegalovirus or Toxoplasma gondii, as well as in\u00a0cases of chronic fatigue syndrome, often of viral or parasitic origin, in the\u00a0context of immune hyperreactivity.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2589\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2245 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2245\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/2lzona\/\" rel=\"bookmark\" aria-label=\"2LZONA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/2lzona\/\" aria-label=\"2LZONA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_ZONA_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 45 F1 &#8211; CNK 1591-064<br \/>\nComposition corresponding to a sequence of 5 capsules:<\/p>\n<p>Formula:<br \/>\nInterleukin 2 (IL-2): 7, 10 CH<br \/>\nInterferon Alpha (IFN-a): 7, 10 CH<br \/>\nDeoxyribonucleic acid (DNA): 8, 10 CH<br \/>\nRibonucleic acid (RNA): 8, 10 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA I: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-HLA II: 10, 18 CH<br \/>\nSpecific Nucleic Acid SNA\u00ae-ZONA: 10, 18 CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<br \/>\nCompositio cytokinae et SNA\u00ae-ZONA ref. 2LZONA<br \/>\nThe areas of use derive from the properties and dilutions of the components.<br \/>\nThey include immune support in viral infections caused by herpes zoster.<\/p>\n<p><span dir=\"ltr\" role=\"presentation\">The change in packaging will be gradual and will take place over the next <\/span><span dir=\"ltr\" role=\"presentation\">few months, gradually affecting each of the medicines currently on the <\/span><span dir=\"ltr\" role=\"presentation\">market. During this transition period, two different box designs (the old and the new) may coexist on the market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2501\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4086 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4086\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/bmp-2-5ch\/\" rel=\"bookmark\" aria-label=\"BMP-2 5CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/bmp-2-5ch\/\" aria-label=\"BMP-2 5CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/2730224_LLB_BMP2-5CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 106 F33 \u2013 CNK 2730-224<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bone Morphogenetic Protein-2 (BMP-2) 5CH<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4090 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4090\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/bmp-4-5ch\/\" rel=\"bookmark\" aria-label=\"BMP-4 5CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/bmp-4-5ch\/\" aria-label=\"BMP-4 5CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/2730216_LLB_BMP4-5CH_2023-gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 107 F33\u2013 CNK 2730-216<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bone Morphogenetic Protein-4 (BMP-4) 5CH<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4102 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4102\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/il-1-27ch\/\" rel=\"bookmark\" aria-label=\"IL-1 27CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/il-1-27ch\/\" aria-label=\"IL-1 27CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/3710928_LLB_IL1-27CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 79\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 31 F33 \u2013 CNK &#8211; 3710-928<\/p>\n<div class=\"page\" title=\"Page 79\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Interleukin 1 (IL-1) 27CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4106 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4106\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/il-2-4ch\/\" rel=\"bookmark\" aria-label=\"IL-2 4CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/il-2-4ch\/\" aria-label=\"IL-2 4CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/LLB_IL2-4CH_2023-gen1_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 34 F33\u2013 CNK &#8211; 3709-847<\/p>\n<div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Interleukin 2 (IL-2) 4CH<\/p>\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4094 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4094\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/en\/productos\/rantes-27ch\/\" rel=\"bookmark\" aria-label=\"RANTES 27CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/en\/productos\/rantes-27ch\/\" aria-label=\"RANTES 27CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/3304425_LLB_RANTES-5CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 150 F33 \u2013 CNK 3304-425<\/p>\n<p>RANTES 27CH<\/p>\n<div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Excipient: sucrose per gelatin capsule<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n<\/div><div class=\"w-grid-preloader\"><div class=\"g-preloader type_custom\">\n\t<div><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"273\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue.png 983w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-150x136.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-70x64.png 70w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div>\n<\/div>\n<\/div>\t<div class=\"w-grid-json hidden\" onclick='return {&quot;action&quot;:&quot;us_ajax_grid&quot;,&quot;ajax_url&quot;:&quot;https:\\\/\\\/med.labolife.com\\\/wp-admin\\\/admin-ajax.php&quot;,&quot;infinite_scroll&quot;:0,&quot;max_num_pages&quot;:1,&quot;pagination&quot;:&quot;infinite&quot;,&quot;permalink_url&quot;:&quot;https:\\\/\\\/med.labolife.com\\\/en\\\/wp-json\\\/wp\\\/v2\\\/pages\\\/1381\\\/&quot;,&quot;template_vars&quot;:{&quot;columns&quot;:&quot;2&quot;,&quot;exclude_items&quot;:&quot;none&quot;,&quot;img_size&quot;:&quot;default&quot;,&quot;ignore_items_size&quot;:0,&quot;items_layout&quot;:&quot;677&quot;,&quot;items_offset&quot;:&quot;1&quot;,&quot;load_animation&quot;:&quot;none&quot;,&quot;overriding_link&quot;:&quot;popup_post&quot;,&quot;post_id&quot;:1381,&quot;query_args&quot;:{&quot;post_type&quot;:[&quot;productos&quot;],&quot;post_status&quot;:[&quot;publish&quot;,&quot;acf-disabled&quot;],&quot;posts_per_page&quot;:&quot;53&quot;},&quot;orderby_query_args&quot;:{&quot;orderby&quot;:{&quot;title&quot;:&quot;ASC&quot;},&quot;order&quot;:&quot;ASC&quot;},&quot;type&quot;:&quot;grid&quot;,&quot;us_grid_ajax_index&quot;:1,&quot;us_grid_filter_params&quot;:null,&quot;us_grid_index&quot;:1,&quot;_us_grid_post_type&quot;:&quot;productos&quot;,&quot;lang&quot;:&quot;en&quot;}}'><\/div>\n\t\t<div class=\"l-popup\">\n\t\t<div class=\"l-popup-overlay\"><\/div>\n\t\t<div class=\"l-popup-wrap\">\n\t\t\t<div class=\"l-popup-box\">\n\t\t\t\t<div class=\"l-popup-box-content\">\n\t\t\t\t\t<div class=\"g-preloader type_custom\">\n\t\t\t\t\t\t<div><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"273\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue.png 983w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-150x136.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-70x64.png 70w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<iframe class=\"l-popup-box-content-frame\" allowfullscreen><\/iframe>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"l-popup-arrow to_next\" title=\"Next\"><\/div>\n\t\t\t\t<div class=\"l-popup-arrow to_prev\" title=\"Previous\"><\/div>\n\t\t\t\t\t\t<div class=\"l-popup-closer\"><\/div>\n\t\t<\/div>\n\t<\/div>\n\t<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"1507 UH 150 F33 \u2013 CNK 3304-425 RANTES 27CH Excipient: sucrose per gelatin capsule","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"content-type":"","footnotes":""},"class_list":["post-1381","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/pages\/1381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/comments?post=1381"}],"version-history":[{"count":19,"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/pages\/1381\/revisions"}],"predecessor-version":[{"id":5678,"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/pages\/1381\/revisions\/5678"}],"wp:attachment":[{"href":"https:\/\/med.labolife.com\/en\/wp-json\/wp\/v2\/media?parent=1381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}